Literature DB >> 34399631

How do we optimize the prescribing of intravenous polymyxins to increase their longevity and efficacy in critically ill patients?

Daniele Roberto Giacobbe1,2, Ilias Karaiskos3, Matteo Bassetti1,2.   

Abstract

Entities:  

Keywords:  Acinetobacter; CMS; Enterobacterales; Pseudomonas; colistin; polymyxin B

Mesh：

Substances：

Year:  2021        PMID： 34399631     DOI： 10.1080/14656566.2021.1961743

Source DB:  PubMed          Journal:  Expert Opin Pharmacother        ISSN： 1465-6566            Impact factor:   3.889


× No keyword cloud information.
  2 in total

Review 1.  Current and Potential Therapeutic Options for Infections Caused by Difficult-to-Treat and Pandrug Resistant Gram-Negative Bacteria in Critically Ill Patients.

Authors:  Helen Giamarellou; Ilias Karaiskos
Journal:  Antibiotics (Basel)       Date:  2022-07-26

2.  Factors Associated with Inadequate Intravenous Colistin Dosages: Post Hoc Analysis of a Multicenter, Cross-Sectional Study.

Authors:  Daniele Roberto Giacobbe; Michele Mirabella; Matteo Rinaldi; Angela Raffaella Losito; Francesca Raffaelli; Filippo Del Puente; Carolina Saffioti; Malgorzata Mikulska; Maddalena Giannella; Pierluigi Viale; Mario Tumbarello; Matteo Bassetti
Journal:  Antibiotics (Basel)       Date:  2021-12-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.